Meera Ramanathan, MD, of the Jules Stein Eye Institute at the University of California in Los Angeles, and a team of researchers have identified three predictive factors that determine the risk of progression and visual loss in open-angle glaucoma patients,…
Ophthalmology
In the UK, Bayer Pharmaceuticals, based in Leverkusen, Germany, has earned approval from the National Institute for Health and Care Excellence for its Eylea as a wet age-related macular degeneration treatment, according to a report by thepharmaletter.
The American Academy of Ophthalmology has released a statement warning Congress of the unintended results of the proposed Pharmaceutical Compounding Quality and Accountability Act, which seeks to crack down on oversights of compounding pharmaceuticals.
BIOLASE, an Irvine, Calif.-based dental laser development and distribution company, has announced that it has earned a U.S. patent covering its laser technologies as a treatment of ophthalmic conditions.
Judy Meyers, DO, has joined the Ophthalmology Associates in Fort Worth, Texas, and will offer optometric services at two of the practice's locations, according to a WatchList News report.
Advertisement
The Association for Research in Vision and Ophthalmology has named Justine Smith, FRANZCO, PhD, FARVO, its new president and William Mieler, MD, its president-elect.
Valeant Pharmaceuticals, based in Quebec, Canada, has acquired ophthalmic products company Bausch + Lomb for $8.7 billion, according to a CNN Money report.
NanoViricides, West Haven, Conn.-based nanobio-pharmaceuticals company, has announced the appointment of Milton Boniuk, MD, as an independent member of its board of directors.
Hoopes Vision has opened an eye surgery facility in Draper, Utah. The facility includes the ambulatory surgery center EyeSurg of Utah, examination rooms, a laser surgery suite and clinical research center.
Allegro Ophthalmics, a San Juan Capistrano, Calif.-based retinal vascular disease treatment company, has partnered with Senju Pharmaceuticals, Osaka, Japan-based ophthalmic preparations company, to develop and market its Integrin Peptide Therapy in Japan.